126 related articles for article (PubMed ID: 37579253)
1. Germline
Oxnard GR; Chen R; Pharr JC; Koeller DR; Bertram AA; Dahlberg SE; Rainville I; Shane-Carson K; Taylor KA; Sable-Hunt A; Sholl LM; Teerlink CC; Thomas A; Cannon-Albright LA; Fay AP; Ashton-Prolla P; Yang H; Salvatore MM; Addario BJ; Jänne PA; Carbone DP; Wiesner GL; Garber JE
J Clin Oncol; 2023 Dec; 41(34):5274-5284. PubMed ID: 37579253
[TBL] [Abstract][Full Text] [Related]
2. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.
Gazdar A; Robinson L; Oliver D; Xing C; Travis WD; Soh J; Toyooka S; Watumull L; Xie Y; Kernstine K; Schiller JH
J Thorac Oncol; 2014 Apr; 9(4):456-63. PubMed ID: 24736066
[TBL] [Abstract][Full Text] [Related]
3. Germline EGFR T790M mutation found in multiple members of a familial cohort.
Yu HA; Arcila ME; Harlan Fleischut M; Stadler Z; Ladanyi M; Berger MF; Robson M; Riely GJ
J Thorac Oncol; 2014 Apr; 9(4):554-8. PubMed ID: 24736080
[TBL] [Abstract][Full Text] [Related]
4. Screening for germline EGFR T790M mutations through lung cancer genotyping.
Oxnard GR; Miller VA; Robson ME; Azzoli CG; Pao W; Ladanyi M; Arcila ME
J Thorac Oncol; 2012 Jun; 7(6):1049-52. PubMed ID: 22588155
[TBL] [Abstract][Full Text] [Related]
5. EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
Lu S; Yu Y; Li Z; Yu R; Wu X; Bao H; Ding Y; Shao YW; Jian H
J Thorac Oncol; 2019 Apr; 14(4):732-736. PubMed ID: 30610926
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of Germline
Hu Y; Alden RS; Odegaard JI; Fairclough SR; Chen R; Heng J; Feeney N; Nagy RJ; Shah J; Ulrich B; Gutierrez M; Lanman RB; Garber JE; Paweletz CP; Oxnard GR
Clin Cancer Res; 2017 Dec; 23(23):7351-7359. PubMed ID: 28947568
[No Abstract] [Full Text] [Related]
7. Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.
Huo R; Li J; Li X; Shi J; Wang K; Jiao J; Shang Y
Oncologist; 2020 Oct; 25(10):826-832. PubMed ID: 32367600
[TBL] [Abstract][Full Text] [Related]
8. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
9. Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family.
Gabriel L; McVeigh T; Macmahon S; Avila Z; Donovan L; Hunt I; Draper A; Minchom A; Popat S; Davidson M; Bhosle J; Milner Watts C; Hubank M; Yuan L; O'Brien M
Lung Cancer; 2024 May; 191():107543. PubMed ID: 38569279
[TBL] [Abstract][Full Text] [Related]
10. Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer.
Alsaddah S; Papadakis AI; Wong N; Palma L; Szlachtycz D; Cruz Marino T; Fiset PO; Foulkes WD
Lung Cancer; 2023 Jul; 181():107247. PubMed ID: 37209596
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.
Mezquita L; Jové M; Nadal E; Kfoury M; Morán T; Ricordel C; Dhooge M; Tlemsani C; Léna H; Teulé A; Álvarez JV; Raimbourg J; Hiret S; Lacroix L; Menéndez M; Saldaña J; Brunet J; Lianes P; Coupier I; Auclin E; Recondo G; Friboulet L; Adam J; Green E; Planchard D; Frébourg T; Capellà G; Rouleau E; Lázaro C; Caron O; Besse B
J Thorac Oncol; 2020 Jul; 15(7):1232-1239. PubMed ID: 32179180
[TBL] [Abstract][Full Text] [Related]
12. Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.
Cheng YI; Gan YC; Liu D; Davies MPA; Li WM; Field JK
BMC Cancer; 2019 Nov; 19(1):1068. PubMed ID: 31703574
[TBL] [Abstract][Full Text] [Related]
13. Two cases of non-small cell lung cancer patients with somatic or germline EGFR R776H mutation.
Guo T; Zhu L; Li W; Lin R; Ding Y; Kang Q; Shao L; Li C; Pan X
Lung Cancer; 2021 Nov; 161():94-97. PubMed ID: 34555730
[TBL] [Abstract][Full Text] [Related]
14.
Sukari A; Nagasaka M; Wakeling E
J Natl Compr Canc Netw; 2017 Oct; 15(10):1188-1192. PubMed ID: 28982744
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer is also a hereditary disease.
Benusiglio PR; Fallet V; Sanchis-Borja M; Coulet F; Cadranel J
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34670806
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
Lee Y; Lee GK; Lee YS; Zhang W; Hwang JA; Nam BH; Kim SH; Kim JH; Yun T; Han JY; Kim HT; Lee JS
Cancer; 2014 Jul; 120(14):2090-8. PubMed ID: 24737599
[TBL] [Abstract][Full Text] [Related]
17. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
Tode N; Kikuchi T; Sakakibara T; Hirano T; Inoue A; Ohkouchi S; Tamada T; Okazaki T; Koarai A; Sugiura H; Niihori T; Aoki Y; Nakayama K; Matsumoto K; Matsubara Y; Yamamoto M; Watanabe A; Nukiwa T; Ichinose M
Cancer Sci; 2017 Jun; 108(6):1263-1270. PubMed ID: 28294470
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations and age at onset of lung adenocarcinoma.
Reckamp KL; Behrendt CE; Slavin TP; Gray SW; Castillo DK; Koczywas M; Cristea MC; Babski KM; Stearns D; Marcum CA; Rodriguez YP; Hass AJ; Vecchio MM; Mora P; Cervantes AE; Sand SR; Mejia RM; Tsou TC; Salgia R; Weitzel JN
Cancer; 2021 Aug; 127(15):2801-2806. PubMed ID: 33858029
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib.
Oya Y; Yoshida T; Asada K; Oguri T; Inui N; Morikawa S; Ito K; Kimura T; Kunii E; Matsui T; Kubo A; Kato T; Abe T; Tsuda T; Hida T
BMC Cancer; 2021 Jan; 21(1):57. PubMed ID: 33435905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
